PRE

Prenetics Global Limited is a health sciences company, which engages in the provision of early detection, prevention, and treatment of cancer. The firm offers IM8, a health and wellness brand which focuses on consumer health products, and Insighta, a joint venture which focuses on the development of early cancer detection technologies. It also focuses on its CircleDNA and ACT Genomics business units. The CircleDNA business unit uses next-generation sequencing (NGS) technology for consumer deoxyribonucleic acid (DNA) test. The ACT Genomics business unit is involved in genomic profiling of solid tumors. It has a presence in the United States. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.